US Patent Issued to Abbott Diabetes Care on July 1 for "Method and apparatus for improving lag correction during in vivo measurement of analyte concentration with analyte concentration variability and range data" (California Inventor)

ALEXANDRIA, Va., July 3 -- United States Patent no. 12,343,140, issued on July 1, was assigned to Abbott Diabetes Care Inc. (Alameda, Calif.).

"Method and apparatus for improving lag correction during in vivo measurement of analyte concentration with analyte concentration variability and range data" was invented by Erwin Satrya Budiman (Fremont, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods, devices, and systems are provided for correcting lag in measurements of glucose concentration level in interstitial fluid. A method includes defining a scaling factor for lag correction, receiving glucose data from the glucose sensor, the sensor data including historical glucose sensor data over a plurali...